SK143594A3 - 1,3,4-oxadiazole-2(3h)-on derivatives, method of their preparation and their terapeutical using - Google Patents
1,3,4-oxadiazole-2(3h)-on derivatives, method of their preparation and their terapeutical using Download PDFInfo
- Publication number
- SK143594A3 SK143594A3 SK1435-94A SK143594A SK143594A3 SK 143594 A3 SK143594 A3 SK 143594A3 SK 143594 A SK143594 A SK 143594A SK 143594 A3 SK143594 A3 SK 143594A3
- Authority
- SK
- Slovakia
- Prior art keywords
- group
- formula
- compound
- carbon atoms
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
- C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9314151A FR2712886B1 (fr) | 1993-11-26 | 1993-11-26 | Dérivés de 1,3,4-oxadiazol-2(3H)-one, leur préparation et leur application en thérapeutique. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK143594A3 true SK143594A3 (en) | 1995-06-07 |
Family
ID=9453245
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1435-94A SK143594A3 (en) | 1993-11-26 | 1994-11-25 | 1,3,4-oxadiazole-2(3h)-on derivatives, method of their preparation and their terapeutical using |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US5525619A (de) |
| EP (1) | EP0655445B1 (de) |
| JP (1) | JPH07196636A (de) |
| KR (1) | KR950014088A (de) |
| CN (1) | CN1106395A (de) |
| AT (1) | ATE157356T1 (de) |
| AU (1) | AU679127B2 (de) |
| CA (1) | CA2136669A1 (de) |
| CZ (1) | CZ291794A3 (de) |
| DE (1) | DE69405198T2 (de) |
| DK (1) | DK0655445T3 (de) |
| ES (1) | ES2107157T3 (de) |
| FI (1) | FI945562A7 (de) |
| FR (1) | FR2712886B1 (de) |
| GR (1) | GR3025272T3 (de) |
| HU (1) | HUT71111A (de) |
| IL (1) | IL111769A (de) |
| NO (1) | NO944513L (de) |
| NZ (1) | NZ264991A (de) |
| PL (1) | PL305999A1 (de) |
| RU (1) | RU94042230A (de) |
| SK (1) | SK143594A3 (de) |
| TW (1) | TW284761B (de) |
| ZA (1) | ZA949394B (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2763068B1 (fr) * | 1997-05-06 | 1999-06-04 | Synthelabo | Derives de 3-(pyrrolidin-3-yl)-1,3,4-oxadiazol-2(3h)-one, leur preparation et leur application en therapeutique |
| FR2766485B1 (fr) * | 1997-07-23 | 2002-05-24 | Synthelabo | Derives de 2,4-dihydro-3h-1,2,4-triazol-3-one, leur prparation et leur application en therapeutique |
| JP2001039954A (ja) * | 1999-05-24 | 2001-02-13 | Tomono Agrica Co Ltd | ヘテロ環誘導体 |
| US6326388B1 (en) * | 1999-12-21 | 2001-12-04 | Celgene Corporation | Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level |
| CN104016938B (zh) * | 2014-05-28 | 2016-08-17 | 浙江工业大学 | 一种含苯硒基的噁二唑类化合物及其制备与应用 |
| CN104016939B (zh) * | 2014-05-28 | 2016-06-15 | 浙江工业大学 | 一种2-亚乙基-3-乙酰基-1,3,4-噁二唑类化合物及其制备与应用 |
| GB201814151D0 (en) * | 2018-08-31 | 2018-10-17 | Ucl Business Plc | Compounds |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2631827B1 (fr) * | 1988-05-27 | 1992-03-27 | Delalande Sa | Nouveaux derives d'(hetero)aryl-5 tetrazole, leur procede de preparation et leur application en therapeutique |
| JPH0366056A (ja) * | 1989-08-03 | 1991-03-20 | Matsushita Electric Ind Co Ltd | 回転ヘッド装置 |
| FR2655044B1 (fr) * | 1989-11-24 | 1995-03-03 | Delalande Sa | Derives d'(hetero) arylmethyloxy-4 phenyl tetrazole et oxadiazole, leur procede de preparation et leur application en therapeutique. |
-
1993
- 1993-11-26 FR FR9314151A patent/FR2712886B1/fr not_active Expired - Fee Related
-
1994
- 1994-11-21 DE DE69405198T patent/DE69405198T2/de not_active Expired - Fee Related
- 1994-11-21 DK DK94402642.6T patent/DK0655445T3/da active
- 1994-11-21 ES ES94402642T patent/ES2107157T3/es not_active Expired - Lifetime
- 1994-11-21 EP EP94402642A patent/EP0655445B1/de not_active Expired - Lifetime
- 1994-11-21 AT AT94402642T patent/ATE157356T1/de not_active IP Right Cessation
- 1994-11-22 JP JP6288124A patent/JPH07196636A/ja not_active Withdrawn
- 1994-11-23 US US08/348,067 patent/US5525619A/en not_active Expired - Fee Related
- 1994-11-25 CN CN94113857A patent/CN1106395A/zh active Pending
- 1994-11-25 CA CA002136669A patent/CA2136669A1/en not_active Abandoned
- 1994-11-25 ZA ZA949394A patent/ZA949394B/xx unknown
- 1994-11-25 SK SK1435-94A patent/SK143594A3/sk unknown
- 1994-11-25 AU AU79030/94A patent/AU679127B2/en not_active Ceased
- 1994-11-25 FI FI945562A patent/FI945562A7/fi not_active Application Discontinuation
- 1994-11-25 RU RU94042230/04A patent/RU94042230A/ru unknown
- 1994-11-25 NO NO944513A patent/NO944513L/no unknown
- 1994-11-25 PL PL94305999A patent/PL305999A1/xx unknown
- 1994-11-25 HU HU9403393A patent/HUT71111A/hu unknown
- 1994-11-25 CZ CZ942917A patent/CZ291794A3/cs unknown
- 1994-11-25 IL IL11176994A patent/IL111769A/xx active IP Right Grant
- 1994-11-25 KR KR1019940031193A patent/KR950014088A/ko not_active Withdrawn
- 1994-11-25 TW TW083110988A patent/TW284761B/zh active
- 1994-11-25 NZ NZ264991A patent/NZ264991A/en unknown
-
1997
- 1997-11-05 GR GR970402910T patent/GR3025272T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO944513L (no) | 1995-05-29 |
| ZA949394B (en) | 1995-09-07 |
| NZ264991A (en) | 1995-07-26 |
| TW284761B (de) | 1996-09-01 |
| RU94042230A (ru) | 1996-11-20 |
| ES2107157T3 (es) | 1997-11-16 |
| ATE157356T1 (de) | 1997-09-15 |
| FI945562L (fi) | 1995-05-27 |
| CA2136669A1 (en) | 1995-05-27 |
| US5525619A (en) | 1996-06-11 |
| EP0655445B1 (de) | 1997-08-27 |
| CN1106395A (zh) | 1995-08-09 |
| FI945562A7 (fi) | 1995-05-27 |
| DE69405198T2 (de) | 1998-01-29 |
| HU9403393D0 (en) | 1995-02-28 |
| KR950014088A (ko) | 1995-06-15 |
| IL111769A (en) | 1999-04-11 |
| AU679127B2 (en) | 1997-06-19 |
| PL305999A1 (en) | 1995-05-29 |
| GR3025272T3 (en) | 1998-02-27 |
| EP0655445A1 (de) | 1995-05-31 |
| AU7903094A (en) | 1995-06-01 |
| IL111769A0 (en) | 1995-01-24 |
| FR2712886A1 (fr) | 1995-06-02 |
| NO944513D0 (no) | 1994-11-25 |
| FR2712886B1 (fr) | 1996-01-05 |
| CZ291794A3 (en) | 1995-07-12 |
| DE69405198D1 (de) | 1997-10-02 |
| JPH07196636A (ja) | 1995-08-01 |
| FI945562A0 (fi) | 1994-11-25 |
| DK0655445T3 (da) | 1998-03-23 |
| HUT71111A (en) | 1995-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1674452A1 (de) | Neues 4-phenylaminobenzaldoximderivatie und dessen verwendung als mek-inhibitor | |
| WO1992012148A1 (en) | 1,4-benzothiazepine derivative | |
| US20100234599A1 (en) | Method for preparing acid addition salts of polyacidic basic compounds | |
| KR20060133592A (ko) | 알킬피페라진- 및 알킬호모피페라진-카르복실레이트의유도체, 이의 제조 방법 및 ｆａａｈ 효소 억제제로서의용도 | |
| JP2840288B2 (ja) | 置換１―（１ｈ―イミダゾール―４―イル）アルキル―ベンズアミド | |
| BG61729B1 (bg) | 9-заместени-2-(2-норм-алкоксифенил)пурин-6-они | |
| EP2623503B1 (de) | Für die behandlung einer durch tcr-nck-interaktion vermittelten krankheit geeignete chromenderivate | |
| US5356916A (en) | 1,2,4-oxadiazole derivatives having monoamine oxidase B enzyme-inhibitory activity | |
| CZ291794A3 (en) | Derivatives of 1,3,4-oxadiazol-2(3h)-one, process of their preparation and their therapeutical use | |
| JP3169188B2 (ja) | カルバミン酸誘導体及びその製造方法 | |
| JP3093419B2 (ja) | １，４‐ベンゾチアゼピン誘導体 | |
| JP2008523031A (ja) | 部分的ドーパミン−ｄ２受容体作動性とセロトニン再摂取阻害の組み合わせを示すフェニルピペラジン誘導体 | |
| US4849423A (en) | Purine derivatives, medicaments containing them and methods of treating cardiac insufficiencies and irregularities with them. | |
| JP2024535860A (ja) | Ｇｐｒ５２モジュレーター化合物 | |
| JP5080458B2 (ja) | ５−ヒドロキシトリプタミンおよびノルエピネフリンの再取込みの阻害のための、またはうつ病障害の治療のための化合物、その製造方法ならびにその使用 | |
| WO1997043282A2 (en) | Benzothiazolinones as anti-asthmatic agents | |
| US5198450A (en) | Phenylalkanoylamine derivatives, process for preparing the same, and usage of the same | |
| HU194193B (en) | Process for preparing new 4-/amino-methylidene/-3-aryl-5/4h/-isoxazolinone derivatives and pharmaceutical compositions containing such compounds as active ingredients | |
| WO2025238416A1 (en) | Indole derivatives, uses and compositions thereof | |
| EP0034752A1 (de) | Phenoxyalkanderivat und Verfahren zu dessen Herstellung | |
| WO2024175985A1 (en) | Development of trimethyllysine hydroxylase (tmlh) inhibitors | |
| EP1709016A1 (de) | Cyclische diaminverbindung und diese enthaltendes pharmazeutikum | |
| HK1186727B (en) | Chromene derivatives useful in the treatment of a disease mediated by the tcr-nck interaction | |
| JPWO1995029163A1 (ja) | イミダゾール誘導体及びその製造方法 |